Futura Medical (GB:FUM) has released an update.
Futura Medical PLC has announced the pre-order availability of its leading sexual health product, Eroxon®, on Amazon, with delivery expected in October 2024. Additionally, the product will hit U.S. store shelves in the same month. Eroxon® is a clinically proven, fast-acting topical gel for the treatment of erectile dysfunction, offering a unique over-the-counter solution in the sexual health market.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.